Indian Bortezomib Exporters: Complete Supplier Ranking with Market Share — 498 Manufacturers (2026) — TransData Nexus

Q: Who is the largest bortezomib buyer importing from India?

EUGIA US LLC, (UNITED STATES) is the largest bortezomib importer from India with a 6.2% market share and import value of $1.3M.

Q: How many bortezomib buyers import from India?

There are 498 active bortezomib buyers importing from India, with a combined import market of $21.9M across 1,383 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top bortezomib buyers from India?

The top 5 bortezomib buyers — EUGIA US LLC,, SUN FARMACUTICA DO BRASIL LTDA, SUN FARMACUTICA DO BRASIL LIMITEDA, EUGIA US LLC, YUSEN LOGISTICS BENELUX BELGIUM — together control 24.6% of total bortezomib import value from India.

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

Market Analysis: Top Importing Countries & Their Importers

1Brazil

Brazil emerges as the first largest importing country, achieving a total trade value of $6.2M through 23 shipments. This represents a market share of 28.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Brazil has a diverse importer base, with their top importers including:

• SUN FARMACUTICA DO BRASIL LTDA - $1.1M (18.6% of country's total business)

• SUN FARMACUTICA DO BRASIL LIMITEDA - $1.0M (16.5% of country's total business)

• SUN FARMACEUTICA DO BRAZIL LTDA. - $584.3K (9.5% of country's total business)

• M/S. SUN FARMACEUTICA DO BRAZIL LTD - $385.4K (6.2% of country's total business)

• SUN FARMACEUTICA DO BRAZIL LIMITEDA - $325.6K (5.3% of country's total business)

• Rest of Brazil's importers - $2.7M (43.9% of country's total business)

Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $268.8K, indicating premium pricing strategy compared to the market average of $15.8K.

Brazil is a key market for Bortezomib imports, representing 28.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Bortezomib buyer market intelligence

1Buyer Segment Analysis

The importers of Bortezomib from India can be categorized into several segments:

1. Distributors: Entities like EUGIA US LLC (United States), YUSEN LOGISTICS BENELUX BELGIUM (Belgium), and AUROLOGISTICS LLC (United States) function as intermediaries, purchasing Bortezomib in bulk and supplying it to healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders to meet the consistent demand from their client base.

2. Hospital Groups: Organizations such as FRESENIUS KABI DEUTSCHLAND GMBH (Germany) and MEDISON PHARMA (Israel) are associated with hospital networks, procuring Bortezomib directly for patient treatment. Their procurement patterns are influenced by patient needs and treatment protocols, leading to regular, sizable orders.

3. Re-exporters: Companies like YUSEN LOGISTICS BENELUX BELGIUM (Belgium) may act as re-exporters, importing Bortezomib for distribution to other regions. Their purchasing behavior is characterized by strategic bulk buying to optimize logistics and meet the demands of secondary markets.

4. Contract Manufacturers: Entities such as SUN FARMACUTICA DO BRASIL LTDA (Brazil) and SUN FARMACUTICA DO BRASIL LIMITEDA (Brazil) may engage in contract manufacturing, importing Bortezomib as an active pharmaceutical ingredient (API) for formulation and packaging. Their procurement is typically aligned with production schedules and contractual obligations, resulting in periodic bulk purchases.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and purchasing behaviors of each buyer category.

Country-Specific Import Regulations

TransData Nexus Bortezomib buyer market intelligence

1Country-Specific Import Regulations

Brazil:

1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA)

2. Import Registration Process: Importers must submit a registration dossier to ANVISA, including product specifications, manufacturing details, and clinical data.

3. Estimated Timeline: The registration process typically takes 6 to 12 months, depending on the completeness of the application and ANVISA's review workload.

4. Import Tariff/Duty: As per the Mercosur Common External Tariff, the import duty for HS code 30049049 is 8%.

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA)

2. Import Registration Process: Importers must ensure that Bortezomib is FDA-approved. Foreign manufacturers must register their facilities with the FDA and comply with the Drug Listing Act.

3. Estimated Timeline: The approval process for a new drug application (NDA) can take 10 to 12 months. For generic drugs, the Abbreviated New Drug Application (ANDA) process may take 8 to 10 months.

4. Import Tariff/Duty: Pharmaceutical products under HS code 30049049 are generally duty-free in the United States.

Israel:

1. Regulatory Authority: Ministry of Health, Pharmaceutical Division

2. Import Registration Process: Importers must obtain registration from the Ministry of Health, submitting documentation on product quality, safety, and efficacy.

3. Estimated Timeline: The registration process usually takes 12 to 18 months.

4. Import Tariff/Duty: Pharmaceutical products are generally exempt from import duties in Israel.

Belgium:

1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP)

Demand Drivers & Market Opportunity

TransData Nexus Bortezomib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Bortezomib is primarily driven by its efficacy in treating multiple myeloma and mantle cell lymphoma. According to the World Health Organization (WHO), multiple myeloma accounted for approximately 176,000 new cases globally in 2020, with a significant burden in countries like the United States and Brazil. The inclusion of Bortezomib in the WHO Model List of Essential Medicines underscores its critical role in cancer treatment protocols.

Government healthcare programs and the expansion of universal health coverage have further bolstered demand. For instance, Brazil's Unified Health System (SUS) provides comprehensive cancer care, including access to essential medications like Bortezomib. Similarly, the United States' Medicare program covers Bortezomib for eligible patients. Tender-based procurement processes, often facilitated by national health authorities or international organizations, ensure a steady supply of Bortezomib to meet patient needs. Our data indicates that 498 buyers across 109 countries have imported Bortezomib from India, reflecting a broad and sustained global demand for this critical oncology drug.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Bortezomib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest bortezomib buyer importing from India?

Based on import volume and value, EUGIA US LLC, (UNITED STATES) leads with $1.3M in imports and a 6.2% market share — the highest of any single bortezomib importer. SUN FARMACUTICA DO BRASIL LTDA (BRAZIL) and SUN FARMACUTICA DO BRASIL LIMITEDA (BRAZIL) are the next largest buyers.

QHow many companies buy bortezomib from India?

There are 498 active bortezomib buyers importing from India, with a combined market of $21.9M across 1,383 shipments to 109 countries. The top 5 buyers hold 24.6% of total import value, while the remaining 493 buyers handle the other 75.4%.

QWhich countries import the most bortezomib from India?

The top importing countries for bortezomib from India are Brazil (28.3%), United States (25.4%), Israel (5.1%), Belgium (4.0%), Germany (3.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of bortezomib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Bortezomib buyer market intelligence

1Buyer Segment Analysis

The importers of Bortezomib from India can be categorized into several segments:

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and purchasing behaviors of each buyer category.

Country-Specific Import Regulations

TransData Nexus Bortezomib buyer market intelligence

1Country-Specific Import Regulations

Brazil:

1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA)

2. Import Registration Process: Importers must submit a registration dossier to ANVISA, including product specifications, manufacturing details, and clinical data.

3. Estimated Timeline: The registration process typically takes 6 to 12 months, depending on the completeness of the application and ANVISA's review workload.

4. Import Tariff/Duty: As per the Mercosur Common External Tariff, the import duty for HS code 30049049 is 8%.

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA)

2. Import Registration Process: Importers must ensure that Bortezomib is FDA-approved. Foreign manufacturers must register their facilities with the FDA and comply with the Drug Listing Act.

3. Estimated Timeline: The approval process for a new drug application (NDA) can take 10 to 12 months. For generic drugs, the Abbreviated New Drug Application (ANDA) process may take 8 to 10 months.

4. Import Tariff/Duty: Pharmaceutical products under HS code 30049049 are generally duty-free in the United States.

Israel:

1. Regulatory Authority: Ministry of Health, Pharmaceutical Division

2. Import Registration Process: Importers must obtain registration from the Ministry of Health, submitting documentation on product quality, safety, and efficacy.

3. Estimated Timeline: The registration process usually takes 12 to 18 months.

4. Import Tariff/Duty: Pharmaceutical products are generally exempt from import duties in Israel.

Belgium:

1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP)

Demand Drivers & Market Opportunity

TransData Nexus Bortezomib buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bortezomib

Bortezomib

Who Buys Bortezomib from India — 498 Importers Behind a $21.9M Market

Top Bortezomib Importers — Ranked by Import Value

Top Bortezomib Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Bortezomib — and from which countries?

Bortezomib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Brazil

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Bortezomib Buyers & Importers

QWho is the largest bortezomib buyer importing from India?

QHow many companies buy bortezomib from India?

QWhich countries import the most bortezomib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2United States

3Israel

4Belgium

5Germany

QWhat is the average import order value for bortezomib from India?

Analysis Methodology